TRxADE HEALTH Inc. (MEDS) Social Stream
TRXADE HEALTH INC (MEDS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MEDS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 2 | $11 | $7 | $8.666 | $5.03 | 72.29% |
| 2022-03-29 | 1 | $8 | $7 | $7.333 | $5.03 | 45.79% |
| 2022-04-01 | 1 | $8 | $6.25 | $7.083 | $5.03 | 40.82% |
| 2022-04-08 | 2 | $8 | $6.25 | $7.083 | $5.03 | 40.82% |
| 2022-05-17 | 2 | $7 | $3.75 | $5.375 | $5.03 | 6.86% |
| 2022-06-03 | 2 | $4 | $3.75 | $3.875 | $5.03 | -22.96% |
| 2022-08-02 | 2 | $4 | $3 | $3.5 | $5.03 | -30.42% |
| 2022-11-14 | 2 | $4 | $1.75 | $2.875 | $5.03 | -42.84% |
| 2022-11-18 | 2 | $2.5 | $1.75 | $2.125 | $5.03 | -57.75% |
| 2023-03-28 | 1 | $1.75 | $1.75 | $1.75 | $5.03 | -65.21% |
| 2023-04-06 | 2 | $1.75 | $1.75 | $1.75 | $5.03 | -65.21% |
| 2023-04-12 | 3 | $1.75 | $0.45 | $1.1 | $5.03 | -78.13% |
| 2023-05-16 | 1 | $18.74 | $18.74 | $18.74 | $5.03 | 272.56% |
| 2023-05-23 | 3 | $1.75 | $0.45 | $1.15 | $5.03 | -77.14% |
| 2023-05-31 | 1 | $18.741 | $18.741 | $18.741 | $5.03 | 272.58% |
| 2023-06-02 | 3 | $18.74 | $6.746 | $13.492 | $5.03 | 168.23% |
| 2023-06-23 | 3 | $18.74 | $6.746 | $13.495 | $5.03 | 168.29% |
The Trend in the Analyst Price Target
Over the past 23 months, MEDS's average price target has gone up $7.45.
Over the past 87 days, MEDS's average upside potential has been 1,465.25%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-12 | 3 | 1.750 | 0.450 | 1.100 | 0.301 | 265.45% |
| 2023-05-16 | 1 | 1.750 | 0.450 | 1.150 | 0.330 | 248.48% |
| 2023-05-16 | 3 | 1.750 | 0.450 | 1.150 | 0.330 | 248.48% |
| 2023-05-31 | 1 | 18.741 | 18.741 | 18.741 | 0.280 | 6593.21% |
| 2023-06-02 | 3 | 1.250 | 0.450 | 0.900 | 0.325 | 176.92% |
MEDS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
MEDS's average broker recommendation rating improved by 0.17 over the prior 52 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- MEDS has a greater number of analysts covering the stock than 98.96% of all US stocks.
- TRXADE HEALTH INC's average analyst price target is higher than 74.45% of Wholesale stocks.
- To contextualize these metrics, consider that out of Wholesale stocks, TRXADE HEALTH INC's upside potential (average analyst target price relative to current price) is greater than 1140.93% of them.
- To contextualize these metrics, consider that out of Wholesale stocks, TRXADE HEALTH INC's variance in analysts' estimates is lower than -1236.71% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Wholesale industry with the ratings most similar to TRXADE HEALTH INC are SGBX, GDC, and IGC.
View All Top Stocks by Price Target
Is MEDS a Buy, Hold or Sell? See the POWR Ratings now!